KLK8

KLK8

A gene on chromosome 19q13.3 that encodes a serine protease that catalyses the degradation of casein, fibrinogen, kininogen, fibronectin and collagen type IV. It cleaves L1CAM in response to increased neural activity, and induces neurite outgrowth and fasciculation of cultured hippocampal neurons.
References in periodicals archive ?
We have examined the prognostic value of alternative mRNA variants of the KLK8 [6] (kallikrein-related peptidase 8) gene.
KLK8 was originally cloned from a human skin library (9) as a homolog of a gene encoding mouse neuropsin.
To analyze KLK8 gene expression, we based the design and synthesis of primer sets on the published mRNA sequence of KLK8-T1 (set KLK8, GenBank accession no.
The KLK8 mRNAs were used to classify KLK8 gene activity as negative or positive.
KLK8 was highly abundant in the esophagus, skin (adult and fetal), and tonsil, with lower concentrations in the adrenal gland (adult and fetal), breast, kidney (adult and fetal), fetal liver, salivary gland, and vagina.
The highest concentrations of KLK8 were found in breast milk and CVF.
We confirmed KLK8 presence in the ovary, esophagus, kidney, salivary gland, skin, tonsil, breast, and cervix, as reported (28).
Very restricted (tissue) Tissue abundance restricted (tissue) Wide KLK2 (prostate) KLK5 (skin, salivary, breast, esophagus) KLK1 KLK3 (prostate) KLK6 (brain/central nervous system) KLK4 KLK7 (esophagus, heart, liver, skin) KLK9 KLK8 (breast, esophagus, skin, tonsil) KLK10 KLK13 (esophagus, tonsil) KLK11 KLK12 KLK14 KLK15
30) found no overexpression of the 15 tissue kallikreins in breast cancer tissue compared with healthy breast tissue and down-regulation of the expression of at least 4 tissue kallikrein genes (KLK5, KLK6, KLK8, and KLK10) in breast cancer tissue.
According to the official kallikrein gene nomenclature, KLK8 is the gene and hK8 is the protein (8).
The 887-base fragment containing the full-length KLK8 cDNA was cut with EcoRI restriction enzyme from the KLK8/pGEM-T Easy plasmid (9) and ligated into the EcoRI sites of the pVL1393 transfer vector (PharMingen) to create plasmid KLK8/pVL1393.
The cells were then infected with 100 [micro]L of stock baculovirus solution containing full-length KLK8 cDNA (1.